Regulatory Submission Blog

Enhancing Study Quality and Data Integrity in the Preclinical Phase

Unifying Science and Safety to Navigate the Iterative Path of Lead Optimization

Discover how Instem’s Advance™, Predict™, and BioRails® accelerate early-stage drug discovery by unifying in silico insights, experimental data, and streamlined workflows.

With integrated, insight‑driven platforms that cut through data complexity and eliminate fragmented workflows, Instem empowers researchers to reduce risk, boost efficiency, and accelerate the journey from discovery to IND submission.

NAMs have the potential to deliver more efficient safety assessments, enabling faster and more confident development decisions while also supporting more ethical drug development.

SEND Implementation Guide v4.0 is the biggest change I’ve seen to the standard in the 15 years I’ve been involved. Here’s what you need to know.